1. Melanoma Res. 2022 Apr 1;32(2):124-127. doi: 10.1097/CMR.0000000000000773.

Response of metastatic melanoma with a rare BRAF V600K mutation to dabrafenib 
and trametinib.

Kromer C(1), Vlahova LD(1), Julius K(1), Schnabel V(1), Schön MP(1)(2), 
Reuter-Jessen K(3), Seif Amir Hosseini A(4), Kretschmer L(1).

Author information:
(1)Department of Dermatology, Venereology, and Allergology, University Medical 
Center, Göttingen.
(2)Lower Saxony Institute of Occupational Dermatology, University Medical Center 
Göttingen.
(3)Department of Pathology, University Medical Center and.
(4)Department of Diagnostic and Interventional Radiology, University Medical 
Center Göttingen, Germany.

DOI: 10.1097/CMR.0000000000000773
PMID: 35254334